loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Daclatasvir

    Client Email Product
    Menu

    Daclatasvir

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 654Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 206843 / DOSAGE - TABLET;ORAL - EQ 90MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DACLATASVIR DIHYDROCHLORIDE(UNII: 50ZO25C11D)
    (DACLATASVIR - UNII:LI2427F9CI)     		DACLATASVIR30mg | 60mg | 90mg

    Inactive Ingredients

    Ingredient Name
    E.R. Squibb & Sons, L.L.C.
    ALUMINUM OXIDE(LMI26O6933)
    ANHYDROUS LACTOSE(3SY5LH9PMK)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    FD&C BLUE NO. 2(L06K8R7DQK)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
    INDIGOTINDISULFONATE SODIUM(D3741U8K7L)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POLYETHYLENE GLYCOL 400(B697894SGQ)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    TITANIUM DIOXIDE(15FIX9V2JP)